Adalat cc and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adalat cc and Paclitaxel. Common interactions include loss of consciousness among females and haematemesis among males.

The phase IV clinical study analyzes what interactions people who take Adalat cc and Paclitaxel have. It is created by eHealthMe based on reports of 11 people who take Adalat cc and Paclitaxel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 05, 2022

11 people who take Adalat cc and Paclitaxel together, and have interactions are studied.


What is Adalat cc?

Adalat cc has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 4,894 Adalat cc users for its effectiveness, alternative drugs and more.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 67,557 Paclitaxel users for its effectiveness, alternative drugs and more.

Number of Adalat cc and Paclitaxel reports submitted per year:

Adalat cc and Paclitaxel drug interactions.

Common Adalat Cc and Paclitaxel drug interactions by gender *:

female:

  1. Loss of consciousness
  2. Altered state of consciousness
  3. Ascites
  4. Chest pain
  5. Cough
  6. Dyspnoea
  7. Embolism
  8. Epistaxis
  9. Hypoaesthesia
  10. Oedema

male:

  1. Haematemesis
  2. Peritonitis
  3. Performance status decreased
  4. Pyrexia
  5. Blood pressure decreased
  6. Cardio-respiratory arrest
  7. Gastric ulcer
  8. Gastritis erosive
  9. General physical health deterioration
  10. Haemoptysis

Common Adalat Cc and Paclitaxel drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Altered state of consciousness
  2. Confusional state
  3. Leukoencephalopathy
  4. Metastases to meninges

50-59:

n/a

60+:

  1. Loss of consciousness
  2. Ascites
  3. Pain in extremity
  4. Palmar-plantar erythrodysaesthesia syndrome
  5. Peritonitis
  6. Pleural effusion
  7. Proteinuria
  8. Pyrexia
  9. Renal failure
  10. Vomiting

Common conditions people have *:

  1. Stress And Anxiety: 4 people, 36.36%
  2. Nausea And Vomiting: 4 people, 36.36%
  3. Nausea (feeling of having an urge to vomit): 4 people, 36.36%
  4. Joint Pain: 4 people, 36.36%
  5. Indigestion: 4 people, 36.36%
  6. Diarrhea: 4 people, 36.36%
  7. Depression: 4 people, 36.36%
  8. Breast Pain: 4 people, 36.36%
  9. Breast Cancer Metastatic: 4 people, 36.36%
  10. Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat cc and Paclitaxel?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Adalat cc and Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adalat cc interactions:

Browse all interactions between Adalat cc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Paclitaxel interactions:

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine and paclitaxel (the active ingredients of Adalat cc and Paclitaxel, respectively), and Adalat cc and Paclitaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Adalat cc and Paclitaxel.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: